Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Qing Xiao Wang, Xiang Chen, Zi Ling Li, Yan Chun Gong & Xiang Yuan Xiong. (2022) Transferrin/folate dual-targeting Pluronic F127/poly(lactic acid) polymersomes for effective anticancer drug delivery. Journal of Biomaterials Science, Polymer Edition 33:9, pages 1140-1156.
Read now
Read now
Solmaz Mojarad-Jabali, Somayeh Mahdinloo, Masoud Farshbaf, Muhammad Sarfraz, Yousef Fatahi, Fatemeh Atyabi & Hadi Valizadeh. (2022) Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancer. Expert Opinion on Drug Delivery 19:6, pages 685-705.
Read now
Read now
Yu. A. Tereshkina, T. I. Torkhovskaya, E. G. Tikhonova, L. V. Kostryukova, M. A. Sanzhakov, E. I. Korotkevich, Yu. Yu. Khudoklinova, N. A. Orlova & E. F. Kolesanova. (2022) Nanoliposomes as drug delivery systems: safety concerns. Journal of Drug Targeting 30:3, pages 313-325.
Read now
Read now
Articles from other publishers (21)
美霞 王. (2024) Research Status of Anti-Aging Drugs in Non-Small Cell Lung Cancer. Advances in Clinical Medicine 14:01, pages 1490-1500.
Crossref
Crossref
Deepika Radhakrishnan, Vaishwik Patel, Shan Mohanan, Kavitha Ramadass, Ajay Karakoti & Ajayan Vinu. (2023) Folic acid functionalised mesoporous core-shell silica nanoparticles loaded with carboplatin for lung cancer therapy. Microporous and Mesoporous Materials 360, pages 112708.
Crossref
Crossref
Zijun Qian, Xiaoting Tian, Yayou Miao, Xin Xu, Xuehua Cheng, Mengyi Wu & Yongchun Yu. (2023) Bufalin inhibits the proliferation of lung cancer cells by suppressing Hippo-YAP pathway. Cellular Signalling 109, pages 110746.
Crossref
Crossref
Akmal M. Asrorov, Muzaffar Kayumov, Nurkhodja Mukhamedov, Ansor Yashinov, Ziyoda Mirakhmetova, Yongzhuo Huang, Abulimiti Yili, Haji Akber Aisa, Mugrajitdin Tashmukhamedov, Shavkat Salikhov & Sharafitdin Mirzaakhmedov. (2023) Toad venom bufadienolides and bufotoxins: An updated review. Drug Development Research 84:5, pages 815-838.
Crossref
Crossref
Ipshita Menon, Maryam Zaroudi, Yuanzhe Zhang, Elizabeth Aisenbrey & Liwei Hui. (2022) Fabrication of active targeting lipid nanoparticles: Challenges and perspectives. Materials Today Advances 16, pages 100299.
Crossref
Crossref
Na Ying, Xiangde Lin, Meihua Xie & Dongdong Zeng. (2022) Effect of surface ligand modification on the properties of anti-tumor nanocarrier. Colloids and Surfaces B: Biointerfaces 220, pages 112944.
Crossref
Crossref
C. Lin, Yixia Liang, Mingyan Guo, Phei Er Saw & Xiaoding Xu. (2022) Stimuli-responsive polyprodrug for cancer therapy. Materials Today Advances 15, pages 100266.
Crossref
Crossref
VishnuPriya Sampath, Noa Horesh, Ben Sasi, Hiba Zannadeh, Ilana Pogodin, Shiv Vardan Singh, Joseph Deutsch & David Lichtstein. (2022) Synthesis and Biological Evaluation of Novel Bufalin Derivatives. International Journal of Molecular Sciences 23:7, pages 4007.
Crossref
Crossref
Zonghua Tian, Yue Zhao, Yaping Mai, Fangxia Qiao, Jueshuo Guo, Luning Dong, Yang Niu, Guojing Gou & Jianhong Yang. (2022) Nanocrystals with different stabilizers overcome the mucus and epithelial barriers for oral delivery of multicomponent Bufadienolides. International Journal of Pharmaceutics 616, pages 121522.
Crossref
Crossref
Hairong Zeng, Chao Xia, Bei Zhao, Mengmeng Zhu, HaoYue Zhang, Die Zhang, Xin Rui, Huili Li & Yi Yuan. (2022) Folic Acid–Functionalized Metal-Organic Framework Nanoparticles as Drug Carriers Improved Bufalin Antitumor Activity Against Breast Cancer. Frontiers in Pharmacology 12.
Crossref
Crossref
Huili Shao, Bingqian Li, Huan Li, Lei Gao, Chao Zhang, Huagang Sheng & Liqiao Zhu. (2021) Novel Strategies for Solubility and Bioavailability Enhancement of Bufadienolides. Molecules 27:1, pages 51.
Crossref
Crossref
Mingyuan Li, Siyu Ma, Xiangyang Xie, Nan Liu, Zhiping Li, Zhenbo Yang, Guangyu Gao, Shiqin Li, Yuan Li, Shuangshuang Li, Xingguo Mei & Hui Zhang. (2021) Vincristine-doxorubicin co-loaded artificial low-density lipoproteins towards solid tumours. European Journal of Medicinal Chemistry 226, pages 113802.
Crossref
Crossref
Lehe Yang, Feng Zhou, Yan Zhuang, Yanan Liu, Lingyuan Xu, Haiyang Zhao, Youqun Xiang, Xuanxuan Dai, Zhiguo Liu, Xiaoying Huang, Liangxing Wang & Chengguang Zhao. (2020) Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway. British Journal of Cancer 124:3, pages 645-657.
Crossref
Crossref
Wei Wang, Yuhao Hao, Yusheng Liu, Rui Li, Da‐Bing Huang & Yue‐Yin Pan. (2020) Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 13:1.
Crossref
Crossref
Li-Juan Deng, Yong Li, Ming Qi, Jun-Shan Liu, Sheng Wang, Li-Jun Hu, Yu-He Lei, Ren-Wang Jiang, Wei-Min Chen, Qi Qi, Hai-Yan Tian, Wei-Li Han, Bao-Jian Wu, Jia-Xu Chen, Wen-Cai Ye & Dong-Mei Zhang. (2020) Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment. European Journal of Pharmacology 887, pages 173379.
Crossref
Crossref
Yongli Zhang, Sihan Wang, Haixia Wang, Yingjie Yang & Jin Gao. (2020) Enhanced Anticancer Therapeutic Delivery to Tumor Microenvironment via Simultaneous Angiogenesis and Tumor Targeting. ChemNanoMat 6:9, pages 1346-1356.
Crossref
Crossref
Zhaohai Pan, Yongchuan Luo, Yuan Xia, Xin Zhang, Yao Qin, Wenjing Liu, Minjing Li, Xiaona Liu, Qiusheng Zheng & Defang Li. (2020) Cinobufagin induces cell cycle arrest at the S phase and promotes apoptosis in nasopharyngeal carcinoma cells. Biomedicine & Pharmacotherapy 122, pages 109763.
Crossref
Crossref
Ana Macedo, Patrícia Filipe, Natália G. Thomé, João Vieira, Carolina Oliveira, Catarina Teodósio, Raquel Ferreira, Luís Roque & Pedro Fonte. (2020) A Brief Overview of the Oral Delivery of Insulin as an Alternative to the Parenteral Delivery. Current Molecular Medicine 20:2, pages 134-143.
Crossref
Crossref
Chien-shan Cheng, Jiaqiang Wang, Jie Chen, Kuei Ting Kuo, Jian Tang, Huifeng Gao, Lianyu Chen, Zhen Chen & Zhiqiang Meng. (2019) New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin. Cancer Cell International 19:1.
Crossref
Crossref
Michaela Jung, Christina Mertens, Elisa Tomat & Bernhard Brüne. (2019) Iron as a Central Player and Promising Target in Cancer Progression. International Journal of Molecular Sciences 20:2, pages 273.
Crossref
Crossref
Regina M. Graham, Emel Kirbas Cilingir, Sajini D. Hettiarachchi, Yiqun Zhou, Braulio CLB Ferreira, Steven Vanni & Roger M. Leblanc. (2022) Carbon Dot Nanoarchitectonics: Quadruple Conjugated Nano Model for Superior Cancer Cell-Nucleus Targeting and Multi Drug Delivery. SSRN Electronic Journal.
Crossref
Crossref